Journal of Medicinal Chemistry · 2007 · 139 citations · 17 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructural BiologyFragment-based Drug DesignFragment-based Lead DiscoveryHit-to-lead OptimizationLead Compound DesignLead DiscoveryLigand BindingFragment-based DiscoveryFragment-based Lead DesignFragment-based Ligand DesignIterative DesignIterative Design ProcessProtein Kinase InhibitorsStructure-based Lead DiscoveryStructure-guided Lead Discovery
Using fragment-based screening techniques, 5-methyl-4-phenyl-1H-pyrazole (IC50 80 microM) was identified as a novel, low molecular weight inhibitor of protein kinase B (PKB). Herein we describe the rapid elaboration of highly potent and ligand efficient analogues using a fragment growing approach. Iterative structure-based design was supported by protein-ligand structure determinations using a PKA-PKB "chimera" and a final protein-ligand structure of a lead compound in PKBbeta itself.
17
The maximal affinity of ligands
Irwin D. Kuntz, K. Chen, Kim A. Sharp et al. · Proceedings of the National Academy of Sciences · 1999 · 845 citations
Fragment-Based Lead Discovery Using X-ray Crystallography
Michael J. Hartshorn, Christopher W. Murray, Anne Cleasby et al. · Journal of Medicinal Chemistry · 2004 · 423 citations